Rifaximin Oral Tablet
2017/00977
Approved small_molecule completed
Quick answer
Rifaximin Oral Tablet for Irritable Bowel Syndrome With Diarrhea is a Approved program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- Irritable Bowel Syndrome With Diarrhea
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed